Age effect on pupil dilation among Alzheimer's patients

Journal of the American Geriatrics Society

Volumn 47, Issue 2, 1999, Pages 257-258

  Takagi, Ayumi ^a   Ishihara, Shin'ya ^a   Kondo, Takaaki ^a   Sakakibara, Hisataka ^a   Toyoshima, Hideaki ^a   Kono, Kazuhiko ^b   Iguchi, Akihisa ^a   Yoshida, Futoshi ^c   Miyao, Masaru ^d  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Central Hospital   (Japan)

^c Aichi Prefectural Colony ^*  (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; LETTER; MALE; MYDRIASIS; NEUROPHYSIOLOGY; PUPIL REFLEX;

EID: 0032907602     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb04589.x     Document Type: Letter

References (10)

1. Scinto LF, Daffner KR, Dressler D, et al.,. A potential noninvasive neurobiological test for Alzheimer's disease. Science 1994; 266: 1051-1054.
2. Loupe DN, Newman NJ, Green RC, et al.,. Pupillary response to tropicamide in patients with Alzheimer disease. Ophthalmology 1996; 103: 495-503.
3. Treloar A, Assin M, Macdonald A,. Detecting Alzheimer's disease. Science (letter) 1995; 267: 1578.
4. Arai H, Terajima M, Nakagawa T, et al.,. Pupil dilatation assay by tropicamide is modulated by apolipoprotein E4 allele dosage in Alzheimer's disease. Neuroreport 1996; 7: 918-920.
5. Growdon JH, Graefe K, Tennis M, et al.,. Pupil dilation to tropicamide is not specific for Alzheimer disease. Arch Neurol 1997; 54: 841-844.
6. The American Psychiatric Association. DSM-III-R. Washington, DC: The American Psychiatric Association 1987, pp. 103-109.
7. McKhann G, Drachman D, Folstein M, et al.,. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
8. Coyle JT, Oster-Granite ML, Gearhart JD,. The neurobiologic consequences of Down syndrome. Brain Res Bull 1986; 16: 773-787.
9. Potter H,. Review and hypothesis: Alzheimer disease and Down syndrome-Chromosome 21 nondisjunction may underlie both disorders. Am J Hum Genet 1991; 48: 1192-1200.
10. Hardy J, Goate A, Owen M, Rossor M,. Presenile dementia associated with mosaic trisomy 21 in a patient with a Down syndrome child. Lancet 1989; ii: 743.